Leukemia Research
Volume 24, Issue 12 , Pages 1059-1062, December 2000

Pericardial effusion in chronic myelomonocytic leukemia (CMML): a case report and review of the literature

  • Corinna Strupp

      Affiliations

    • Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine-University, 40225 Düsseldorf, Germany
    • Corresponding Author InformationCorresponding author: Tel.: +49-211-8117720; fax: +49-211-8118853
  • ,
  • Ulrich Germing

      Affiliations

    • Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine-University, 40225 Düsseldorf, Germany
  • ,
  • Ingo Trommer

      Affiliations

    • Department of Cardiology, Heinrich-Heine-University, Düsseldorf, Germany
  • ,
  • Norbert Gattermann

      Affiliations

    • Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine-University, 40225 Düsseldorf, Germany
  • ,
  • Carlo Aul

      Affiliations

    • Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine-University, 40225 Düsseldorf, Germany

Received 8 April 2000; accepted 6 June 2000.

Abstract 

Pericardial effusion is a rare but potentially life-threatening complication of chronic myelomonocytic leukemia. A case of a 70-year-old female with CMML is reported, who developed a severe pericardial effusion after an initially stable course of disease. She underwent pericardiocentesis and subsequent intracardial instillation of mitoxantrone with poor response. Subxiphoid pericardiotomy was successfully performed. Leukocytosis did not respond to hydroxyurea. Because of decreasing performance status of the patient systemic chemotherapy was not applied and the patient died within 2 weeks. A review of the literature shows that there is no effective treatment for pericardial effusion in CMML, and some common features may be noted.

Keywords:  Chronic myelomonocytic leukemia, Pericardial effusion, Pericardiocentesis, Hyperleukocytosis, Extramedullary manifestations

Abbreviations:  AML, acute myeloid leukemia, CMML, chronic myelomonocytic leukemia, FAB, French-American-British, LDH, lactate dehydrogenase, MDS, myelodysplastic syndrome, MPD, myeloproliferative disorder, WBC, white blood count

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0145-2126(00)00078-3

doi:10.1016/S0145-2126(00)00078-3

Leukemia Research
Volume 24, Issue 12 , Pages 1059-1062, December 2000